Development of Selective M5 Muscarinic Acetylcholine Receptor Negative Allosteric Modulators for the Prevention of Opioid Misuse and Relapse

被引：0
|
作者：
Jones, Carrie [1 ]
Gould, Robert [1 ]
Gunter, Barak [1 ]
Bubser, Michael [1 ]
Matthews, Robert [1 ]
Teal, Laura [1 ]
Robb, Hudson [1 ]
Ragland, Madeline [1 ]
Bridges, Tom [1 ]
Garrison, Aaron [1 ]
Winder, Danny [1 ]
Lindsley, Craig [1 ]
机构：
[1] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2019年 / 44卷 / SUPPL 1期
关键词：
M5 Muscarinic Receptor; Negative Allosteric Modulator; Opioid Use Disorder; Oxycodone;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
W159
引用
下载
收藏
页码：470 / 471
页数：2
相关论文
共 50 条
  • [41] Substituted Benzylspiroindolin-2-one Analogues as Positive Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1
    Rotella, David P.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (09): : 822 - 822
  • [42] M1 muscarinic acetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease
    Decker, Michael
    Holzgrabe, Ulrike
    MEDCHEMCOMM, 2012, 3 (07) : 752 - 762
  • [43] Evaluation of 1,2,5-thiadiazoles as modulators of M1/M5 muscarinic receptor subtypes
    Maheshwari, Aditya
    Rao, P. S. S.
    Messer, William S., Jr.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (06) : 1838 - 1844
  • [44] Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M1
    Spearing, Paul K.
    Cho, Hyekyung P.
    Luscombe, Vincent B.
    Blobaum, Anna L.
    Boutaud, Olivier
    Engers, Darren W.
    Rodriguez, Alice L.
    Niswender, Colleen M.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Bender, Aaron M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 47
  • [45] Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice
    Thomsen, M
    Woldbye, DPD
    Wörtwein, G
    Fink-Jensen, A
    Wess, J
    Caine, SB
    JOURNAL OF NEUROSCIENCE, 2005, 25 (36): : 8141 - 8149
  • [46] Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice
    Thomsen, M
    Woldbye, DP
    Woertwein, G
    Fink-Jensen, A
    Wess, J
    Caine, SB
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S88 - S88
  • [47] Low allosteric agonism and moderate modulation are required for optimal therapeutic window for positive allosteric modulators of the M1 muscarinic acetylcholine receptor
    Nguyen, Huong Thi Mai
    van der Westhuizen, Emma
    Khajehali, Elham
    Christopoulos, Arthur
    Valant, Celine
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 411 - 412
  • [48] Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice
    Yamada, M
    Lamping, KG
    Duttaroy, A
    Zhang, WL
    Cui, YH
    Bymaster, FP
    McKinzie, DL
    Felder, CC
    Deng, CX
    Faraci, FM
    Wess, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) : 14096 - 14101
  • [49] Estrogen prevents cerebrovascular deficits by the lack of M5 muscarinic acetylcholine receptor through MAPK activation
    Araya, Runa
    Kitamura, Naohito
    Kimura, Tetsuya
    Wess, Jurgen
    Yamada, Masahisa
    NEUROSCIENCE RESEARCH, 2007, 58 : S61 - S61
  • [50] Muscarinic acetylcholine receptor M5 is involved in spermatogenesis through the modification of cell-cell junctions
    Han, Xiao
    Zhang, Cong
    Ma, Xiangping
    Yan, Xiaowei
    Xiong, Bohui
    Shen, Wei
    Yin, Shen
    Zhang, Hongfu
    Sun, Qingyuan
    Zhao, Yong
    REPRODUCTION, 2021, 162 (01) : 47 - 59
12345